Cost-Of-Illness of Inflammatory Bowel Disease Patients Treated With Anti-Tumour Necrosis Factor: A French Large Single-Centre Experience

United European Gastroenterology Journal - United States
doi 10.1177/2050640619853448
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Psychiatric Illness in Patients With Inflammatory Bowel Disease.

Gut
Gastroenterology
1987English

Editorial: CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Alpha Agent (Infliximab), in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Increase in Bone Mineral Density of Patients With Spondyloarthropathy Treated With Anti-Tumour Necrosis Factor Alpha

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Tumor Necrosis Factor Alpha in Inflammatory Bowel Disease.

Gut
Gastroenterology
1994English

Review Article: Consensus Statements on Therapeutic Drug Monitoring of Anti-Tumour Necrosis Factor Therapy in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Prevalence and Pathogenesis of Anemia in Inflammatory Bowel Disease. Influence of Anti-Tumor Necrosis Factor- Treatment

Haematologica
Hematology
2009English

Anti-Tumour Necrosis Factor Therapy for Ankylosing Spondylitis: International Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2002English

Patient Perception of Chronic Illness Care in a Large Inflammatory Bowel Disease Cohort

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2013English

Pgi42 - Non-Persistence With Immunosuppresant, Anti-Tumor Necrosis Factor, and Anti-Integrin Agents in Patients With Inflammatory Bowel Disease: A Retrospective Claims Data Analysis in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy